PFC
PGNX

Phocas Financial Corp’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,022,708
Closed -$5.17M 206
2019
Q3
$5.17M Sell
1,022,708
-10,620
-1% -$53.7K 0.55% 77
2019
Q2
$6.38M Sell
1,033,328
-112,964
-10% -$697K 0.68% 66
2019
Q1
$5.32M Sell
1,146,292
-551,957
-33% -$2.56M 0.53% 84
2018
Q4
$7.13M Sell
1,698,249
-38,137
-2% -$160K 0.8% 54
2018
Q3
$10.9M Sell
1,736,386
-26,592
-2% -$167K 0.95% 38
2018
Q2
$14.2M Sell
1,762,978
-16,546
-0.9% -$133K 1.22% 15
2018
Q1
$13.3M Buy
1,779,524
+340,217
+24% +$2.54M 1.2% 20
2017
Q4
$8.56M Sell
1,439,307
-60,978
-4% -$363K 0.72% 64
2017
Q3
$11K Buy
1,500,285
+33,537
+2% +$246 0.92% 47
2017
Q2
$9.96M Buy
1,466,748
+65,491
+5% +$445K 0.9% 47
2017
Q1
$13.2M Sell
1,401,257
-190,205
-12% -$1.8M 1.23% 16
2016
Q4
$13.8M Sell
1,591,462
-1,626
-0.1% -$14K 0.91% 24
2016
Q3
$10.1M Buy
1,593,088
+943,793
+145% +$5.97M 0.7% 45
2016
Q2
$2.74M Buy
649,295
+39,332
+6% +$166K 0.2% 180
2016
Q1
$2.66M Sell
609,963
-25,370
-4% -$111K 0.2% 179
2015
Q4
$3.9M Buy
635,333
+45,414
+8% +$278K 0.31% 156
2015
Q3
$3.37M Buy
589,919
+40,632
+7% +$232K 0.29% 161
2015
Q2
$4.1M Sell
549,287
-706,358
-56% -$5.27M 0.33% 148
2015
Q1
$7.51M Buy
1,255,645
+208,464
+20% +$1.25M 0.6% 70
2014
Q4
$7.92M Sell
1,047,181
-42,564
-4% -$322K 0.69% 43
2014
Q3
$5.66M Buy
1,089,745
+157,865
+17% +$819K 0.51% 90
2014
Q2
$4.02M Buy
931,880
+126,285
+16% +$544K 0.35% 130
2014
Q1
$3.3M Buy
805,595
+180,522
+29% +$738K 0.32% 134
2013
Q4
$3.33M Buy
+625,073
New +$3.33M 0.31% 144